SPARC eligible to get $5 million upon achieving regulatory milestones

13 Jan 2022 Evaluate

Sun Pharma Advanced Research Company (SPARC) is eligible to receive $5 million upon achieving the regulatory milestones for the program developed using SPARC technology. Pursuant to the agreement entered between the parties, SPARC shall also be eligible for additional future milestones and royalties on net sales.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

133.75 -0.30 (-0.22%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 522.50
CMS Info Systems 343.20
Sagility 52.23
Smartworks Coworking 472.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×